340B claims data submission is the process of taking a dispensed prescription, generating a data file through a third-party administrator (TPA), and uploading it to a manufacturer portal within a fixed window, usually 45 days, to keep the 340B price on that claim. For a well-staffed hospital system, that process runs in the background. For […]
340B Claims Data Submission: What It Actually Costs an FQHC Pharmacy Read More »
HRSA audit readiness is the ability to explain, with evidence, why a 340B program operated the way it did on an ordinary day, not just the ability to assemble a binder quickly after an audit letter arrives. That distinction sits at the center of a recent episode of 340B Pulse, the NorthArc Health podcast powered
HRSA Audit Readiness: What 10 Real Audits Taught One 340B Program Read More »
Most 340B programs can produce a binder in three weeks. Very few can explain what their controls were doing in the eleven months before the letter arrived. That gap is the whole subject of this article, and it is where 340B audit readiness either exists or does not. Everything below is drawn from an operator
340B Audit Readiness: The 7 Controls That Hold When Nobody Is Watching Read More »
Most coverage of contract pharmacy restrictions is written from the outside. It tracks lawsuits, manufacturer policy announcements, state legislation, and federal uncertainty. All of that matters. None of it tells you what happens inside a health center on the Monday morning after a new policy drops. Thomasyna Sweed knows that Monday well. She is Program
Contract Pharmacy Restrictions: 6 Rules That Actually Work Read More »
A multi-state 340B program is a single covered-entity operating model applied across hospitals, clinics, pharmacies, vendors, and state regulatory environments that do not match each other. It scales when the organization standardizes its compliance core, documents every justified local exception, and governs vendors on outcomes rather than service levels. That distinction sits at the center
Multi-State 340B Program Management: How Health Systems Scale Without Losing Control Read More »
Strong 340B operations are a set of small, repeatable habits: running the reports that show where prescriptions actually go, reviewing what failed to capture, checking wholesaler invoices against the 340B price, and owning the program rather than delegating it to software. Programs that build these habits absorb pricing and regulatory pressure. Programs that skip them
340B Operations: The 7 Habits That Protect a Program Before Anything Goes Wrong Read More »
Duplicate discount prevention is the process of ensuring a covered entity never claims both a 340B discount and a Medicaid rebate on the same drug unit. It sounds like a narrow compliance task. In practice, it depends on data quality, billing accuracy, Medicaid decisions, vendor processes, and ongoing review working together, which is exactly why
Duplicate Discount Prevention: What Actually Has to Work Behind the Scenes Read More »
What Is the 340B Rebate Model Pilot, and Why Is It Back Now? The 340B rebate model pilot is HRSA’s proposed replacement for upfront 340B discounts. Under this model, for a defined set of drugs, instead of getting the purchase price, covered entities would dispense at full price and then submit a rebate request to
340B Rebate Model Pilot: HRSA’s 2027 Comeback Read More »
340B rebate readiness is the operational capacity to identify, validate, submit, and reconcile claims under a rebate-based 340B model, then confirm that the rebate actually received matches what was owed. It is not the act of uploading a file once a month. Done correctly, it is a continuous cycle of data cleanup, exception handling, and
340B Rebate Readiness: Why the Five-Hour Myth Is Actually an Iceberg Read More »
What Did Arkansas Attorney General Tim Griffin Actually File? Arkansas Attorney General Tim Griffin filed suit against 22 defendants: 13 drug manufacturers, their related corporate entities, and data management firm Second Sight Solutions in Polk County Circuit Court. The complaint alleges the defendants engaged in deceptive business practices and violated Arkansas’ 2021 law requiring 340B-participating
Arkansas Sues Drugmakers Over 340B: What Covered Entities Should Know Read More »
